Zoe Bollinger
Sep 1, 2015

Pharma Backed Patent Law Change Would Raise Medicare Costs

A patent law change sought by the pharmaceutical industry could cost federal health-care programs $1.3 billion over a decade by delaying new generic medicines, an analysis by the Congressional Budget Office found this summer

Drug-Industry Rule Would Raise Medicare Costs - WSJ
A patent law change pushed by the pharmaceutical industry could cost federal health-care programs $1.3 billion over a decade by delaying new generic drugs, the Congressional Budget Office estimates.